Skip to main content
KARD
NASDAQ Life Sciences

Kardigan Shares Soar 38% on Nasdaq Debut After $400M Upsized IPO

Tom Rudovsky · Reported by Binance News
More coverage: Healthcare
Sentiment info
Positive
Importance info
9
Price
$22
Mkt Cap
0
52W Low
0
52W High
0
52W Position
Off High
Rel. Volume
Market data snapshot near publication time

Summary

Kardigan's stock surged 38% in its Nasdaq trading debut, following an upsized initial public offering that raised $400 million. This strong first-day performance significantly exceeds earlier reports of a modest gain. The heart-health biotech priced 25 million shares at $16.00 each, indicating robust investor demand for the new issue.

At the time of this announcement, KARD was trading at $22.00 on NASDAQ in the Life Sciences sector. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Binance News.


Price Chart

Share this article

Copied!

KARD - Latest Insights

KARD
Jun 29, 2026, 4:05 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $25.90
Real-time Price: $20.70 info
Change: -$5.20 (-20%) info
Market Cap: $1.927B info
KARD
Jun 25, 2026, 4:00 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $22.58
Real-time Price: $20.70 info
Change: -$1.88 (-8%) info
Market Cap: $1.927B info
KARD
Jun 23, 2026, 6:05 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.78
Real-time Price: $20.70 info
Change: -$2.08 (-9%) info
Market Cap: $1.927B info
KARD
Jun 18, 2026, 5:14 PM EDT
Filing Type: 424B4
Importance Score:
9
Price at Filing: $20.43
Real-time Price: $20.70 info
Change: +$0.270 (+1%) info
Market Cap: $1.927B info
KARD
Jun 18, 2026, 12:42 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $17.72
Real-time Price: $20.70 info
Change: +$2.98 (+17%) info
Market Cap: $1.927B info